Midterm Exam: NR 568 / NR568
(Latest Update )
Advanced Pharmacology for the
Adult-Gerontology Primary Care
Nurse Practitioner | Questions with
Answers | 100% Correct | Grade A –
Chamberlain
Question:
Treatment of bacterial sinusitis with dose
Answer:
· Amoxicillin 500 mg PO TID or 875 mg PO BID for 5-7 days (adults)
Question:
Treatment of bacterial respiratory system infections
Answer:
· Amoxicillin 500 mg, 2 tablets TID for 5 days; if allergy to pcn - doxy 100 mg
one tablet bid for 5 days; if allergy to doxy, azithromycin 250mg, 2 tablets day
1, then one tablet daily for 4 days
,Question:
· Treatment of bacterial ear infections -
Answer:
o External topical ciprofloxacin .3% otic drops;
o otitis media - amoxicillin or amoxicillin/clavulanate for 5-10 days w/o
penicillin allergy; if pcn allergy erythromycin and sulfisoxazole
Question:
Treatment of Borrelia burgdorferi infection
Answer:
Single-dose doxycycline PO for a bite; 100 mg orally (PO) twice daily (BID) for
10-21 days for infection.
Question:
Treatment of Clostridium difficile colitis
Answer:
· 10 days of oral vancomycin 125 mg po QID or fidaxomicin (Dificid) 200 mg
PO BID x 10 days (if severe, longer treatment, add on metronidazole)
,Question:
Treatment of bacterial conjunctivitis
Answer:
· caused by staph or strep Polymyxin-trimethoprim ophthalmic drops for 7-10
days
Question:
Treatment of bacterial
Answer:
Cefotaxime and ampicillin IV until the causative agent is identified. Or
Penicilin G; monitor for rash; cephalosporin can penetrate csf
Question:
o Laboratory monitoring for patients receiving antiretroviral therapy (ART)
Answer:
1. CD4, viral load(plasma HIV),
2. Watch for lactic acid, ast/alt, cbc for anemia, neutropenia
, Question:
o Treatment goals for antiretroviral therapy (ART)
Answer:
delay or reverse loss of immune function, decrease certain AIDS-related
complications, preserve health, prolong life, and decrease HIV transmission
Question:
Entry inhibitor - maraviroc
Answer:
1. HIV binds to CD4 cells via gp120 protein for attachment maraviroc a ccr5
chemokine receptor 5 antagonist blocks this entry into the cell.
SE: cough, rash, dizziness
Question:
Fusion inhibitor - enfuvirtide
Answer:
is a fusion inhibitor that attaches to the gp41 subunit on the virus and
prevents the HIV envelope from merging with the CD4 cell membrane
(Latest Update )
Advanced Pharmacology for the
Adult-Gerontology Primary Care
Nurse Practitioner | Questions with
Answers | 100% Correct | Grade A –
Chamberlain
Question:
Treatment of bacterial sinusitis with dose
Answer:
· Amoxicillin 500 mg PO TID or 875 mg PO BID for 5-7 days (adults)
Question:
Treatment of bacterial respiratory system infections
Answer:
· Amoxicillin 500 mg, 2 tablets TID for 5 days; if allergy to pcn - doxy 100 mg
one tablet bid for 5 days; if allergy to doxy, azithromycin 250mg, 2 tablets day
1, then one tablet daily for 4 days
,Question:
· Treatment of bacterial ear infections -
Answer:
o External topical ciprofloxacin .3% otic drops;
o otitis media - amoxicillin or amoxicillin/clavulanate for 5-10 days w/o
penicillin allergy; if pcn allergy erythromycin and sulfisoxazole
Question:
Treatment of Borrelia burgdorferi infection
Answer:
Single-dose doxycycline PO for a bite; 100 mg orally (PO) twice daily (BID) for
10-21 days for infection.
Question:
Treatment of Clostridium difficile colitis
Answer:
· 10 days of oral vancomycin 125 mg po QID or fidaxomicin (Dificid) 200 mg
PO BID x 10 days (if severe, longer treatment, add on metronidazole)
,Question:
Treatment of bacterial conjunctivitis
Answer:
· caused by staph or strep Polymyxin-trimethoprim ophthalmic drops for 7-10
days
Question:
Treatment of bacterial
Answer:
Cefotaxime and ampicillin IV until the causative agent is identified. Or
Penicilin G; monitor for rash; cephalosporin can penetrate csf
Question:
o Laboratory monitoring for patients receiving antiretroviral therapy (ART)
Answer:
1. CD4, viral load(plasma HIV),
2. Watch for lactic acid, ast/alt, cbc for anemia, neutropenia
, Question:
o Treatment goals for antiretroviral therapy (ART)
Answer:
delay or reverse loss of immune function, decrease certain AIDS-related
complications, preserve health, prolong life, and decrease HIV transmission
Question:
Entry inhibitor - maraviroc
Answer:
1. HIV binds to CD4 cells via gp120 protein for attachment maraviroc a ccr5
chemokine receptor 5 antagonist blocks this entry into the cell.
SE: cough, rash, dizziness
Question:
Fusion inhibitor - enfuvirtide
Answer:
is a fusion inhibitor that attaches to the gp41 subunit on the virus and
prevents the HIV envelope from merging with the CD4 cell membrane
